Modular RNA nanoparticles safely match clinical adjuvant potency in vaccine studies

Jan 11, 2026 Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while avoiding the autoimmune risks that limit existing alternatives. (Nanowerk Spotlight) Every vaccine faces the same fundamental challenge: getting the immune system to pay attention. Antigens alone often fail to provoke responses...